文献速递胃肠外科围术期管理与 ERAS

肌肉减少症与胃肠道肿瘤术后并发症风险的荟萃分析

Sarcopenia and Postoperative Complication Risk in Gastrointestinal Surgical Oncology: A Meta-analysis.
PubMed 文献 · Ann Surg · 2018-01-01

荟萃分析显示,肌肉减少症与主要并发症(RR 1.40,95%CI 1.20-1.64,P<0.001)和总并发症(RR 1.35,95%CI 1.12-1.61,P=0.001)风险增加相关,但评估方法缺乏共识限制了临床转化。

要点

  • 术前肌肉减少症增加胃肠道肿瘤术后主要和总并发症风险。
  • 肌肉减少症定义与评估方法异质性大,患病率12%-78%。
  • 建议结合肌肉量与身体功能评估以提高预后价值。

核心结论

  • 肌肉减少症与胃肠道肿瘤切除术后并发症风险增加相关。
  • 评估方法缺乏共识妨碍了结果的解释和临床应用。

研究设计与样本

  • 系统检索EMBASE、Web of Science和PubMed从2004年至2017年1月31日的文献。
  • 按Clavien-Dindo分级定义总并发症(≥2级)和主要并发症(≥3级)。

主要发现

  • 术前肌肉减少症患病率范围为12%至78%。
  • 肌肉减少症患者主要并发症风险比为1.40(95%CI 1.20-1.64;P<0.001;I²=52%)。
  • 肌肉减少症患者总并发症风险比为1.35(95%CI 1.12-1.61;P=0.001;I²=60%)。
  • 亚组分析显示肌肉减少症在不同定义、评估方法、研究质量和诊断中均为一致的风险因素。

临床怎么用

  • 术前可考虑评估肌肉减少症以辅助风险分层。
  • 结合肌肉量测量与身体功能评估可能提高预后准确性。

局限性

  • 肌肉减少症评估方法缺乏统一标准,研究间异质性中等。
  • 缺乏方法学共识限制了结果的解释和临床利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the study was to evaluate sarcopenia as a predictor of postoperative risk of major and total complications after surgery for gastrointestinal cancer. BACKGROUND: Sarcopenia is associated with poor survival in gastrointestinal cancer patients, but the role of sarcopenia as prognostic tool in surgical oncology has not been established, and no consensus exists regarding assessment and management of sarcopenic patients. METHODS: We performed a systematic search for citations in EMBASE, Web of Science, and PubMed from 2004 to January 31, 2017. Random effects meta-analyses were used to estimate the pooled risk ratio for postoperative complications by Clavien-Dindo grade (total complications: grade ≥2; major complications: grade ≥3) in patients with sarcopenia versus patients without sarcopenia. Stratified analyses were performed by sarcopenia criteria, cutoff level, assessment methods, study quality, cancer diagnosis, and "Enhanced Recovery After Surgery" care. RESULTS: Twenty-nine studies (n = 7176) were included with sarcopenia prevalence ranging between 12% and 78%. Preoperative incidence of sarcopenia was associated with increased risk of major complications (risk ratio 1.40; 95% confidence interval, 1.20-1.64; P < 0.001; I = 52%) and total complications (risk ratio 1.35; 95% confidence interval, 1.12-1.61; P = 0.001; I = 60%). Moderate heterogeneity was found for both meta-analyses. Subgroup analyses showed that sarcopenia remained a consistent risk factor across stratification by sarcopenia criteria, assessment methods, study quality, and diagnoses. CONCLUSIONS: Sarcopenia was associated with an increased risk of complications after gastrointestinal tumor resection, but lack of methodological consensus hampers the interpretation and clinical utilization of these findings. Combining assessment of muscle mass with measures of physical function may increase the prognostic value and accuracy in preoperative risk stratification.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia and Postoperative Complication Risk in Gastrointestinal Surgical Oncology: A Meta-analysis. Ann Surg. 2018. PMID: 29373365. doi:10.1097/SLA.0000000000002679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。